Personalised exhaled nitric oxygen fraction (


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 07 01 2020
accepted: 24 03 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 24 9 2020
Statut: epublish

Résumé

The aim of this study was to identify patients who benefit most from exhaled nitric oxide fraction ( We used data from 179 adults with asthma from a 12-month primary care randomised controlled trial with 3-monthly assessments of We found a difference between the Ca and FCa strategy for the mean dosage of beclomethasone strategy of 223 µg (95% CI 6-439), p=0.04) and for the total costs of asthma medication a mean reduction of US$159 (95% CI US$33-285), p=0.03) in patients with a low baseline In primary care,

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to identify patients who benefit most from exhaled nitric oxide fraction (
METHODS METHODS
We used data from 179 adults with asthma from a 12-month primary care randomised controlled trial with 3-monthly assessments of
RESULTS RESULTS
We found a difference between the Ca and FCa strategy for the mean dosage of beclomethasone strategy of 223 µg (95% CI 6-439), p=0.04) and for the total costs of asthma medication a mean reduction of US$159 (95% CI US$33-285), p=0.03) in patients with a low baseline
CONCLUSIONS CONCLUSIONS
In primary care,

Identifiants

pubmed: 32963989
doi: 10.1183/23120541.00351-2019
pii: 00351-2019
pmc: PMC7487343
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: S. Boer has nothing to disclose. Conflict of interest: P.J. Honkoop has nothing to disclose. Conflict of interest: R.J.B. Loijmans has nothing to disclose. Conflict of interest: J.B. Snoeck-Stroband has nothing to disclose. Conflict of interest: W.J.J. Assendelft has nothing to disclose. Conflict of interest: T.R.J. Schermer reports projects grants for the study from the Netherlands Organisation for Health Research and Development, and the Dutch Lung Foundation, during the conduct of the study. Conflict of interest: J.K. Sont reports an unrestricted research grant from GSK Netherlands outside the submitted work.

Références

BMC Pulm Med. 2011 Nov 24;11:53
pubmed: 22114896
Lancet. 2008 Sep 20;372(9643):1065-72
pubmed: 18805335
Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30
pubmed: 15817806
Lancet. 2006 Aug 26;368(9537):780-93
pubmed: 16935689
J Asthma. 2008 Sep;45(7):523-31
pubmed: 18773320
Chest. 2008 Apr;133(4):837-9
pubmed: 18398112
Respir Med. 2013 Jul;107(7):943-52
pubmed: 23601567
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):490-6
pubmed: 10934076
J Allergy Clin Immunol. 2011 Feb;127(2):355-60
pubmed: 21281866
Allergy Asthma Proc. 2018 Jan 1;39(1):27-35
pubmed: 29279057
Allergy Asthma Proc. 2018 Sep 13;39(5):338-344
pubmed: 30103840
Am J Respir Crit Care Med. 2009 Jan 15;179(2):93-7
pubmed: 18931330
Respir Med. 2006 Apr;100(4):616-21
pubmed: 16226443
Respir Med. 2012 Aug;106(8):1158-63
pubmed: 22682550
J Allergy Clin Immunol. 2015 Mar;135(3):682-8.e11
pubmed: 25174865
Am J Respir Crit Care Med. 2007 Aug 1;176(3):231-7
pubmed: 17496226
Am J Respir Crit Care Med. 2005 Oct 1;172(7):831-6
pubmed: 15976380
Respir Res. 2006 Apr 20;7:67
pubmed: 16626491
Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15
pubmed: 21885636
Prim Care Respir J. 2009 Dec;18(4):320-7
pubmed: 19888541
Thorax. 1996 May;51(5):496-502
pubmed: 8711677
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Eur Respir J. 2016 Feb;47(2):410-9
pubmed: 26828055
Am Rev Respir Dis. 1993 Apr;147(4):832-8
pubmed: 8466117
Clin Sci (Lond). 2017 May 1;131(10):1027-1043
pubmed: 28487412
Thorax. 2014 Nov;69 Suppl 1:1-192
pubmed: 25323740
N Engl J Med. 2005 May 26;352(21):2163-73
pubmed: 15914548
Am J Respir Crit Care Med. 2001 Sep 1;164(5):738-43
pubmed: 11549525
Cochrane Database Syst Rev. 2016 Sep 01;9:CD011440
pubmed: 27580628

Auteurs

Suzanne Boer (S)

Dept of Biomedical Data Sciences, Section of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands.
Dept of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.

Persijn J Honkoop (PJ)

Dept of Biomedical Data Sciences, Section of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands.

Rik J B Loijmans (RJB)

Dept of General Practice, Academic Medical Centre, Amsterdam, The Netherlands.

Jiska B Snoeck-Stroband (JB)

Dept of Biomedical Data Sciences, Section of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands.

Willem J J Assendelft (WJJ)

Dept of Primary and Community Care, Radboud University Medical Centre, Nijmegen, The Netherlands.

Tjard R J Schermer (TRJ)

Dept of Primary and Community Care, Radboud University Medical Centre, Nijmegen, The Netherlands.

Jacob K Sont (JK)

Dept of Biomedical Data Sciences, Section of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands.

Classifications MeSH